People in prisons and other closed settings
The estimated global HIV prevalence in prisoners is 3%. In some settings, the HIV prevalence in prison is 15 times higher than in the general adult population. Recommended HIV prevention and treatment services are usually unavailable in prison settings: only about 5% of countries have needle/syringe programmes in prisons and only 1 in 3 provide prison based opioid substitution therapy. Condoms are available to prisoners in only 28 countries, although they are accessible through programmes in community settings worldwide.
WHO, working with UNODC and other partners, supports the implementation of comprehensive HIV services for people who live in prisons or other closed settings, including harm reduction services for those who use drugs.
Status report on prison health in the WHO European Region (2019)
Focus on key populations in national HIV strategic plans in the WHO African Region
Opening Speech at AIDS 2018
WHO launches new guidelines on cryptococcal disease at CROI 2018
Global partners call for new strategies to end HIV among key populations